Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
According to a report in the Wall Street Journal, Costco ($COST) is about to launch its own Medicare Advantage plan in two states as part of a limi...
Acadia Pharmaceuticals Inc (ACAD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 42,912,904 | $1,085,696,471 | +1% | 5.44% |
| 2. | Palo Alto Investors William Leland Edwards | 2,864,096 | $72,461,629 | -1% | 10.01% |
| 3. | Point72 Asset Management Steve Cohen | 2,433,168 | $61,559,150 | -6% | 0.07% |
| 4. | Citadel Investment Group Ken Griffin | 2,182,177 | $55,209,078 | +251% | 0.01% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,969,445 | $49,826,959 | +26% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 259,109 | $6,646,145.85 | 39,317,673 | 2023-05-24 | Filing | |
| $25.65 | 24,113 | $618,498.45 | 3,610,443 | 2023-05-24 | Filing | |
| $25.51 | 28,878 | $736,787.52 | 39,058,564 | 2023-05-24 | Filing | |
| $25.51 | 2,688 | $68,581.09 | 3,586,330 | 2023-05-24 | Filing | |
| $25.27 | 218,171 | $5,513,682.96 | 39,029,686 | 2023-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.34 | 9,292 | $272,604.05 | 67,828 | 2026-08-06 | Filing | |
| $29.00 | 5,000 | $145,000.00 | 77,120 | 2026-08-06 | Filing | |
| $29.00 | 5,849 | $169,637.96 | 67,828 | 2026-08-05 | Filing | |
| $26.17 | 50 | $1,308.50 | 18,994 | 2026-07-30 | Filing | |
| $26.13 | 16,508 | $431,354.04 | 19,044 | 2026-07-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,515,173 | $569,633,876 | 0.01% | |
| 2. | 9,076,212 | $229,628,164 | 0.01% | |
| 3. | 8,838,450 | $223,612,785 | 0.01% | |
| 4. | 7,144,524 | $180,756,457 | 1.54% | |
| 5. | 5,763,750 | $145,822,875 | 0% |
News See All
Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2026 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2026 Earnings Call Transcript May 6, 2026ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.04.
ACADIA (ACAD) Upgraded to Buy After Recent Pullback
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc.
10 Most Profitable Biotech Stocks to Buy Now
In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now.
ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds
We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. ACADIA Pharmaceuticals Inc. is one of the most undervalued healthcare stocks to buy now.
9 Most Undervalued Healthcare Stocks to Buy Now
In this article, we will be taking a look at the 9 Most Undervalued Healthcare Stocks to Buy Now.
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.'s (ACAD) Therapeutic Domains
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 10 Fastest Growing Mid Cap Stocks to Buy Now. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the fastest growing stocks.
10 Fastest Growing Mid Cap Stocks to Buy Now
In this article, we will be taking a look at the 10 Fastest Growing Mid Cap Stocks to Buy Now.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2025 Earnings Call Transcript February 26, 2026 Operator: Thank you for standing by. My name is JL, and I will be your conference operator today.
Hedge Fund Resource Center